Form EFFECT Cerevel Therapeutics

May 26, 2022 6:09 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: May 25, 2022 4:01 P.M.
Form: S-3
CIK: 0001805387
Company Name: Cerevel Therapeutics Holdings, Inc.
File Number: 333-264812


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings